| Valley Physicians Medical Group, Inc. | |
|
841 W Valley Blvd Suite 104 Alhambra CA 91803-3251 | |
| (626) 282-3113 | |
| (626) 289-9179 |
| Full Name | Valley Physicians Medical Group, Inc. |
|---|---|
| Speciality | Family Medicine |
| Location | 841 W Valley Blvd, Alhambra, California |
| Authorized Official Name and Position | Prasert Basil Vassantachart (OWNER) |
| Authorized Official Contact | 6262823113 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Valley Physicians Medical Group, Inc. 841 W Valley Blvd Suite 104 Alhambra CA 91803-3251 Ph: (626) 282-3113 | Valley Physicians Medical Group, Inc. 841 W Valley Blvd Suite 104 Alhambra CA 91803-3251 Ph: (626) 282-3113 |
| NPI Number | 1376538132 |
|---|---|
| Provider Enumeration Date | 09/16/2005 |
| Last Update Date | 09/01/2011 |
| Medicare PECOS PAC ID | 9638349244 |
|---|---|
| Medicare Enrollment ID | O20110908001850 |
News Archive
Physical therapists are calling for definitive vestibular screenings and assessment measures for US military service members with blast-induced traumatic brain injuries (BITBI). According to a Scholarly Opinion Piece in the September issue of Physical Therapy, the scientific journal of the American Physical Therapy Association (APTA), vestibular rehabilitation must be included as part of successful treatment for those who have been injured by blasts and experience vestibular symptoms such as vertigo, gaze instability, and motion intolerance.
Soligenix, Inc., a clinical stage biopharmaceutical company focused on developing products to treat serious inflammatory diseases where there remains an unmet medical need, as well as developing several biodefense vaccines and therapeutics, announced today that the National Institute of Allergy and Infectious Diseases has awarded Soligenix a Small Business Innovation Research grant to support further preclinical development of SGX943 as a treatment for melioidosis.
A new Mayo Clinic study may help physicians differentially diagnose three common neurodegenerative disorders in the future. The study will be presented at the Alzheimer's Association International Conference on Alzheimer's Disease on July 11 in Vienna.
Savient Pharmaceuticals, Inc. reported financial results for the three and six months ended June 30, 2010. The net loss for the second quarter of 2010 was $5.0 million, or $0.07 per basic and diluted share, on total revenues of $1.0 million, compared with a net loss of $54.8 million, or $0.92 per basic and diluted share on total revenues of $0.7 million for the second quarter of 2009.
Unlikely on the face of it, perhaps, but a consortium including Cranfield Impact Centre and Nissan Technical Centre Europe, has developed a prototype bone density scanning system which could be used to improve driver and passenger restraint systems in cars.
› Verified 6 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1376538132 | NPI | - | NPPES |
| GR0016470 | Medicaid | CA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | GH4008 (California) | Primary |
| Provider Name | Prasert Basil Vassantachart |
|---|---|
| Provider Type | Practitioner - General Practice |
| Provider Identifiers | NPI Number: 1295720050 PECOS PAC ID: 1254501869 Enrollment ID: I20110908001876 |
News Archive
Physical therapists are calling for definitive vestibular screenings and assessment measures for US military service members with blast-induced traumatic brain injuries (BITBI). According to a Scholarly Opinion Piece in the September issue of Physical Therapy, the scientific journal of the American Physical Therapy Association (APTA), vestibular rehabilitation must be included as part of successful treatment for those who have been injured by blasts and experience vestibular symptoms such as vertigo, gaze instability, and motion intolerance.
Soligenix, Inc., a clinical stage biopharmaceutical company focused on developing products to treat serious inflammatory diseases where there remains an unmet medical need, as well as developing several biodefense vaccines and therapeutics, announced today that the National Institute of Allergy and Infectious Diseases has awarded Soligenix a Small Business Innovation Research grant to support further preclinical development of SGX943 as a treatment for melioidosis.
A new Mayo Clinic study may help physicians differentially diagnose three common neurodegenerative disorders in the future. The study will be presented at the Alzheimer's Association International Conference on Alzheimer's Disease on July 11 in Vienna.
Savient Pharmaceuticals, Inc. reported financial results for the three and six months ended June 30, 2010. The net loss for the second quarter of 2010 was $5.0 million, or $0.07 per basic and diluted share, on total revenues of $1.0 million, compared with a net loss of $54.8 million, or $0.92 per basic and diluted share on total revenues of $0.7 million for the second quarter of 2009.
Unlikely on the face of it, perhaps, but a consortium including Cranfield Impact Centre and Nissan Technical Centre Europe, has developed a prototype bone density scanning system which could be used to improve driver and passenger restraint systems in cars.
› Verified 6 days ago
News Archive
Physical therapists are calling for definitive vestibular screenings and assessment measures for US military service members with blast-induced traumatic brain injuries (BITBI). According to a Scholarly Opinion Piece in the September issue of Physical Therapy, the scientific journal of the American Physical Therapy Association (APTA), vestibular rehabilitation must be included as part of successful treatment for those who have been injured by blasts and experience vestibular symptoms such as vertigo, gaze instability, and motion intolerance.
Soligenix, Inc., a clinical stage biopharmaceutical company focused on developing products to treat serious inflammatory diseases where there remains an unmet medical need, as well as developing several biodefense vaccines and therapeutics, announced today that the National Institute of Allergy and Infectious Diseases has awarded Soligenix a Small Business Innovation Research grant to support further preclinical development of SGX943 as a treatment for melioidosis.
A new Mayo Clinic study may help physicians differentially diagnose three common neurodegenerative disorders in the future. The study will be presented at the Alzheimer's Association International Conference on Alzheimer's Disease on July 11 in Vienna.
Savient Pharmaceuticals, Inc. reported financial results for the three and six months ended June 30, 2010. The net loss for the second quarter of 2010 was $5.0 million, or $0.07 per basic and diluted share, on total revenues of $1.0 million, compared with a net loss of $54.8 million, or $0.92 per basic and diluted share on total revenues of $0.7 million for the second quarter of 2009.
Unlikely on the face of it, perhaps, but a consortium including Cranfield Impact Centre and Nissan Technical Centre Europe, has developed a prototype bone density scanning system which could be used to improve driver and passenger restraint systems in cars.
› Verified 6 days ago
Ssg Apctc Alhambra Center Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1635 W Main St Ste 100, Alhambra, CA 91801 Phone: 626-248-1800 | |
Patient Care Medical Center Inc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 320 S Garfield Ave Ste 206, Alhambra, CA 91801 Phone: 626-607-9406 Fax: 626-458-2489 | |
Thelma V Buan Md Inc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 123 N Garfield Ave, Suite C, Alhambra, CA 91801 Phone: 626-308-3781 Fax: 626-308-2113 | |
Paul Hovsepian, M.d. Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 103 N Garfield Ave, Suite F, Alhambra, CA 91801 Phone: 626-282-2100 Fax: 626-281-0969 | |
Thida Win Md Inc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 100 S Raymond Ave, Alhambra, CA 91801 Phone: 626-677-8218 | |
Apc-lsma Designated Shareholder Medical Corporation Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 925 S Garfield Ave, Alhambra, CA 91801 Phone: 626-282-0282 | |
Ap-amh 2 Medical Corporation Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1668 S Garfield Ave Fl 2, Alhambra, CA 91801 Phone: 626-282-0288 |